Manitex Capital invests $740k in Ortho Regenerative Technologies
Canadian private investment firm Manitex Capital has acquired a 44 percent equity interest in Ortho Regenerative Technologies Inc (Ortho RTi), a Kirkland, Québec-based biotechnology company that develops medical devices for unmet needs in the orthopedics market. The transaction is comprised of a $500,000 equity investment and a $240,000 credit facility. Ortho RTi this week agreed to acquire and develop a platform technology for the repair and regeneration of damaged joints, including the knee and shoulder, from Québec innovation hub Univalor and Polytechnique Montréal.
12 August 2015•3 mins read
